HRT Not Linked To Cognitive Problems In Women 50 To 55

Editor's Choice Academic Journal Main Category: Menopause Also Included In: Women's Health / Gynecology Article Date: 26 Jun 2013 - 0:00 PDT

Current ratings for: HRT Not Linked To Cognitive Problems In Women 50 To 55

The study showed that postmenopausal hormone therapy with conjugated equine estrogens (CEEs) is not linked to overall sustained benefit or risk to cognitive function in women of this age group.

The therapy consists of a synthetic mixture of estrogen and is used to treat the symptoms of menopause, such as hot flashes and vaginal dryness.

A previous report, the Women's Health Initiative Memory Study (WHIMS), found that women ages 65 and older taking postmenopausal hormone therapy with CEEs experienced deficits in global and domain-specific cognitive functioning.

The authors explained that until now, it was not known whether the treatment had the same effect on younger women.

Therefore, the new study, the Women's Health Initiative Memory Study of Younger Women (WHIMSY), analyzed whether younger postmenopausal women taking CEE-based hormone therapy resulted in longer-term influences on cognitive function.

The team of experts, led by Mark A. Espeland, Ph.D., of the Wake Forest School of Medicine, Winston-Salem, N.C., presented the primary results from this investigation in JAMA Internal Medicine.

The researchers said:

A total of 1,326 postmenopausal women were involved in the research, they had begun treatment in two randomized placebo-controlled clinical trials of hormone therapy when aged 50 to 55 years.

Go here to read the rest:
HRT Not Linked To Cognitive Problems In Women 50 To 55